首页> 外文OA文献 >Use of Colistin and Other Critical Antimicrobials on Pig and Chicken Farms in Southern Vietnam and Its Association with Resistance in Commensal Escherichia coli Bacteria
【2h】

Use of Colistin and Other Critical Antimicrobials on Pig and Chicken Farms in Southern Vietnam and Its Association with Resistance in Commensal Escherichia coli Bacteria

机译:越南南部养猪场和养鸡场中共利斯汀和其他关键抗菌药的使用及其与共生大肠杆菌耐药性的关系

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Antimicrobial resistance (AMR) is a global health problem, and emerging semi-intensive farming systems in Southeast Asia are major contributors to the AMR burden. We accessed 12 pig and chicken farms at key stages of production in Tien Giang Province, Vietnam, to measure antimicrobial usage and to investigate the prevalence of AMR to five critical antimicrobials (β-lactams, third-generation cephalosporins, quinolones, aminoglycosides, and polymyxins) and their corresponding molecular mechanisms among 180 Escherichia coli isolates. Overall, 94.7 mg (interquartile range [IQR], 65.3 to 151.1) and 563.6 mg (IQR, 398.9 to 943.6) of antimicrobials was used to produce 1 kg (live weight) of chicken and pig, respectively. A median of 3 (out of 8) critical antimicrobials were used on pig farms. E. coli isolates exhibited a high prevalence of resistance to ampicillin (97.8% and 94.4% for chickens and pigs, respectively), ciprofloxacin (73.3% and 21.1%), gentamicin (42.2% and 35.6%), and colistin (22.2% and 24.4%). The prevalence of a recently discovered colistin resistance gene, mcr-1, was 19 to 22% and had strong agreement with phenotypic colistin resistance. We conducted plasmid conjugation experiments with 37 mcr-1 gene-positive E. coli isolates and successfully observed transfer of the gene in 54.0% of isolates through a plasmid of approximately 63 kb, consistent with one recently identified in China. We found no significant correlation between total use of antimicrobials at the farm level and AMR. These data provide additional insight into the role of mcr-1 in colistin resistance on farms and outline the dynamics of phenotypic and genotypic AMR in semi-intensive farming systems in Vietnam. Our study provides accurate baseline information on levels of antimicrobial use, as well as on the dynamics of phenotypic and genotypic resistance for antimicrobials of critical importance among E. coli over the different stages of production in emerging pig and poultry production systems in Vietnam. E. coli isolates showed a high prevalence of resistance (>20%) to critically important antimicrobials, such as colistin, ciprofloxacin, and gentamicin. The underlying genetic mechanisms identified for colistin (the mcr-1 gene) and quinolone (gyrA gene mutations) are likely to play a major role in AMR to those compounds. Conjugation experiments led to the identification of a 63-kb plasmid, similar to one recently identified in China, as the potential carrier of the mcr-1 gene. These results should encourage greater restrictions of such antimicrobials in Southeast Asian farming systems
机译:抗菌素耐药性(AMR)是一个全球性的健康问题,东南亚新兴的半精养系统是造成AMR负担的主要因素。我们访问了越南田江省处于关键生产阶段的12个养猪场和养鸡场,以测量抗菌剂的使用情况并调查AMR对五种关键抗菌剂(β-内酰胺类,第三代头孢菌素,喹诺酮类,氨基糖苷类和多粘菌素)的患病率)及其在180株大肠杆菌中的相应分子机制。总体而言,分别使用94.7 mg(四分位间距[IQR],65.3至151.1)和563.6 mg(IQR,398.9至943.6)抗菌剂来生产1 kg(活重)的鸡和猪。在养猪场中使用了3种关键抗微生物剂(共8种)。大肠杆菌分离株对氨苄西林(分别对鸡和猪分别为97.8%和94.4%),环丙沙星(73.3%和21.1%),庆大霉素(42.2%和35.6%)和大肠菌素(22.2%和24.4%)。最近发现的大肠菌素抗性基因mcr-1的患病率为19%至22%,与表型大肠菌素抗性有很强的一致性。我们对37个mcr-1基因阳性的大肠杆菌进行了质粒结合实验,并成功地通过约63 kb的质粒成功地观察到54.0%的菌株中该基因的转移,这与中国最近发现的一个质粒一致。我们发现农场一级抗菌药物的总使用量与AMR之间没有显着相关性。这些数据提供了对mcr-1在农场的粘菌素抗性中的作用的进一步了解,并概述了越南半集约化耕作系统中表型和基因型AMR的动态。我们的研究提供了有关越南新兴猪和家禽生产系统中不同生产阶段的大肠杆菌中至关重要的抗菌药物使用水平以及表型和基因型耐药性动态的准确基准信息。大肠杆菌分离株对重要的重要抗菌素(例如大肠菌素,环丙沙星和庆大霉素)的耐药率很高(> 20%)。针对大肠菌素(mcr-1基因)和喹诺酮(gyrA基因突变)确定的潜在遗传机制可能在这些化合物的AMR中起主要作用。结合实验导致鉴定出一个63 kb的质粒,该质粒与mcr-1基因的潜在载体相似,该质粒与中国最近鉴定的质粒相似。这些结果应鼓励在东南亚的农业系统中更大程度地限制此类抗菌素的使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号